Kızıltunç E, Ünlü S, Yakıcı İ E, Kundi H, Korkmaz A, Çetin M, Örnek E
Cardiology Department, Numune Education and Research Hospital, 06100, Ankara, Turkey.
Cardiology Department, Atatürk Chest Diseases and Chest Surgery Education and Research Hospital, Ankara, Turkey.
Herz. 2020 Nov;45(7):676-683. doi: 10.1007/s00059-018-4769-0. Epub 2018 Nov 23.
Cardiac tamponade (CT) is characterized by compression of the cardiac chambers due to pericardial fluid accumulation. The etiology and prognosis may vary in different regions, and thus patient series from various regions can be useful for exploring the etiological and prognostic disparities. The aim of this study was to determine the clinical characteristics of patients with imminent CT, to evaluate the diagnostic performance of biochemical, microbiologic, and pathologic laboratory analysis, and to ascertain the prognosis of CT patients.
We enrolled all patients with imminent CT who underwent percutaneous pericardiocentesis between July 2012 and December 2017 in this retrospective study. The patients were classified into three etiology groups: (a) malignancy (MRCT); (b) iatrogenic/mechanical complication of myocardial infarction (IMCT); and (c) other causes (OCT). Clinical information, laboratory findings, and survival data were recorded.
In total, 186 pericardiocentesis procedures were performed on 153 consecutive patients with CT. The median follow-up was 137 days (range: 1-1937). The MRCT group had the highest mortality rate (79%) in 12 months, while the OCT group had the lowest rate (27%). We determined that increased age, higher serum urea levels, and malignancy-related CT were independent predictors of mortality. The mortality rates of the MRCT and IMCT groups were similar, with both of them being significantly higher than the rate of the OCT group. In all, 15 patients were diagnosed with a new malignancy via pericardial fluid cytology.
Patients in the MRCT and IMCT groups had a poor prognosis. The presence of malignancy was found to be the most powerful predictor of mortality in CT patients.
心脏压塞(CT)的特征是心包积液导致心腔受压。不同地区的病因和预后可能有所不同,因此来自不同地区的患者系列对于探索病因和预后差异可能有用。本研究的目的是确定即将发生CT的患者的临床特征,评估生化、微生物学和病理学实验室分析的诊断性能,并确定CT患者的预后。
在这项回顾性研究中,我们纳入了2012年7月至2017年12月期间接受经皮心包穿刺术的所有即将发生CT的患者。患者被分为三个病因组:(a)恶性肿瘤(MRCT);(b)心肌梗死的医源性/机械性并发症(IMCT);(c)其他原因(OCT)。记录临床信息、实验室检查结果和生存数据。
总共对153例连续的CT患者进行了186次心包穿刺术。中位随访时间为137天(范围:1 - 1937天)。MRCT组在12个月内的死亡率最高(79%),而OCT组最低(27%)。我们确定年龄增加、血清尿素水平升高和与恶性肿瘤相关的CT是死亡率的独立预测因素。MRCT组和IMCT组的死亡率相似,均显著高于OCT组。共有15例患者通过心包积液细胞学检查诊断为新发恶性肿瘤。
MRCT组和IMCT组患者预后较差。发现恶性肿瘤的存在是CT患者死亡率的最有力预测因素。